NCT03022799View on ClinicalTrials.gov

Phase I, KM-819 in Healthy Subjects for Parkinson's Disease

PHASE1CompletedINTERVENTIONAL
Enrollment

88

Participants

Timeline

Start Date

November 30, 2016

Primary Completion Date

September 30, 2017

Study Completion Date

November 30, 2017

Conditions
Parkinson's Disease
Interventions
DRUG

KM-819

DRUG

Placebo

Trial Locations (1)

13496

CHA Bundang Medical Center, CHA University, Seongnam-si

Sponsors
All Listed Sponsors
lead

Kainos Medicine Inc.

INDUSTRY

NCT03022799 - Phase I, KM-819 in Healthy Subjects for Parkinson's Disease | Biotech Hunter | Biotech Hunter